Obsidian Therapeutics, Inc. Common Stock (OBX)
Its factor scores sit near the middle; none stands out.
OBX scores higher than 63% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Obsidian Therapeutics, Inc. Common Stock (OBX) scores 47 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.92× 30-day average
- 52-week range
- —
- Market cap
- $1.10B
- Earnings date
- —
- Volume
- 532,207
- Avg. volume (30d)
- 576,161
- Open
- 12.25
- Previous close
- 12.24
- Day's range (regular session)
- 12.25 – 13.95
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 5.98
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about OBX right now
Obsidian Therapeutics, Inc. Common Stock (OBX) currently scores 47/100 on the Market Census six-factor composite, at the Average score level. OBX is +6.21% on the day and -4.34% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in OBX's data roughly balance out right now. OBX's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about OBX itself. The weakest factor is Momentum at 29/100 — below average recent price moves. Low momentum + high trend often marks a base-building phase rather than a topping pattern.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See OBX in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent OBX news
Latest headlines that name Obsidian Therapeutics, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual MeetingYahoo
- Obsidian Therapeutics To Present Updated Data In Patients With Immune-Checkpoint Inhibitor-Resistant Advanced Melanoma From Its Phase 1 Study And The Phase 1/2 Agni-01 Multicenter Study Of Amsokigene AutoleucelBenzinga
- Obsidian Therapeutics: A $1.1 Billion Valuation Leaves Little Margin For ErrorSeekingAlpha
We hide 1 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to OBX’s 47, all within 1 point.
Sorted by closeness to OBX’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.